Document is current
Any future updates will be listed below
-
Authors
Agirrezabal, Ion https://orcid.org/0000-0003-3170-7845
Pollock, Richard F. https://orcid.org/0000-0002-9873-7507
Carion, Phuong Lien https://orcid.org/0009-0000-2565-8085
Shergill, Suki https://orcid.org/0000-0001-5319-6770
Brennan, Victoria K. https://orcid.org/0000-0001-7814-2306
Pereira, Helena
Chatellier, Gilles
Vilgrain, Valérie
-
Funding
Funding for this research was provided by:
Sirtex Medical (N/A)
- License Information
-
More Information
Article History
Accepted: 30 August 2024
First Online: 16 October 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki, approved by an ethics committee, and complied with the provisions of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines for Good Clinical Practice.
: Informed consent was obtained from all individual participants included in the study.
: IA was a full-time employee of Sirtex Medical Europe GmbH at the time of the study. RFP is a director, shareholder, and full-time employee of Covalence Research Ltd, which received consultancy fees from Sirtex Medical United Kingdom Ltd to run the analyses, generate tables and figures, and draft the manuscript. PLC was a full-time employee of Sirtex Medical Europe GmbH at the time of the study. VKB was a full-time employee of Sirtex Medical United Kingdom Ltd at the time of the study. SS is a full-time employee and director of Sirtex Medical United Kingdom Ltd. VV declares research funding and speaker fees from Sirtex. HP and GC have no conflicts of interest to declare.
